AmMax Bio., Inc.

The company develops anti-inflammatory, anti-fibrotic, and anti-neovascular therapies targeting CSF1R to treat diseases with significant unmet medical needs. Their technology aims to provide healthcare professionals with effective treatment options for conditions that currently lack adequate therapeutic solutions.

Traction 8/10

Redwood City, United States · HQ

Founded 202017500+ followers

Biotechnology
Healthcare Technology

Updated 2 days ago

Funding

Raised to date

$39MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Larry Hsu

Co-Founder/CEO

Product

Features

The company develops anti-inflammatory, anti-fibrotic, and anti-neovascular therapies targeting CSF1R to treat diseases with significant unmet medical needs. Their technology aims to provide healthcare professionals with effective treatment options for conditions that currently lack adequate therapeutic solutions.